The global pharmaceutical industry will abandon the UK unless the country's National Health Service (NHS) receives an extra £20bn ($£30 billion), warned a major industry trade group. The Association of the British Pharmaceutical Industry (ABPI) argued that the increased rationing of treatments is a sign that the NHS is falling in the ranks of the world's major health systems, leaving patients and drug companies to suffer. UK health spending, presently 9.9% of GDP, should rise to 11.3%, according to the ABPI's published election campaign requests. The demands come as GSK, the UK's biggest drugs company, announced a £2bn rise in first-quarter profits on revenues of £7.4bn.
The global pharmaceutical industry will abandon the UK unless the country's National Health Service (NHS) receives an extra £20bn ($26bn), warned a major industry trade group. The Association of the British Pharmaceutical Industry (ABPI) argued that the increased rationing of treatments is a sign that the NHS is falling in the ranks of the world's major health systems, leaving patients and drug companies to suffer. UK health spending, presently 9.9% of GDP, should rise to 11.3%, according to the ABPI's published election campaign requests. The demands come as GSK, the UK's biggest drugs company, announced a £2bn rise in first-quarter profits on revenues of £7.4bn.